Clinical Trials Directory

Trials / Completed

CompletedNCT01701102

Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery

Optimal Dose of Spinal Mepivacaine Combined With Fentanyl For Knee Arthroscopy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Hospital for Special Surgery, New York · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Prolonged motor block and delayed ability to walk are limitations of spinal anesthesia in ambulatory (same-day) surgery. This can be improved by lowering the dose of local anesthetic (a medication that, when injected around nerves, blocks nerve conduction, resulting in numbness and weakness) used in the spine, but too low a dose can result in an incomplete block (inadequate anesthesia) in some patients. There is evidence that adding a low dose of fentanyl, a narcotic, to mepivacaine enhances the anesthetic effect. The purpose of this study is to determine the lowest dose of mepivacaine, a local anesthetic, when combined with fentanyl, for which spinal anesthesia is adequate for ambulatory knee arthroscopy.

Conditions

Interventions

TypeNameDescription
PROCEDUREMepivacaine (24 mg) plus fentanylMepivacaine (24 mg) and fentanyl (10 µg)
PROCEDUREMepivacaine (27 mg) plus fentanylMepivacaine (27 mg) and fentanyl (10 µg)
PROCEDUREMepivacaine (30 mg) plus fentanylMepivacaine (30 mg) and fentanyl (10 µg)
PROCEDUREMepivacaineMepivacaine 37.5 mg

Timeline

Start date
2011-12-01
Primary completion
2012-07-01
Completion
2013-12-01
First posted
2012-10-04
Last updated
2016-04-05
Results posted
2016-03-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01701102. Inclusion in this directory is not an endorsement.